explore -WSS

explore

author：Wikipedia 2025-09-28 01:38:15 - browse：3

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Brain worms: The science behind RFK Jr.'s parasitic infection

entertainment

WSS

What nurses really want: sufficient staffing for patient care

Prosthetic arm enables patients to feel the objects they grip

Study: AI not yet building 'n

Insmed lung disease drug hits target in key Phase 3 trial

Adam's Biotech Scorecard: Do Sarepta's exon

Steward Health Care files for bankruptcy

focus

explore

knowledge

How to save PrEP access — and even expand it

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Guidelines to prevent youth baseball injuries need more muscle

Startling documents reveal new facets of Sacklers' opioid empire

23andMe had bad news about my health. I wish a person had delivered it

Medicare says breakthrough device reimbursement rule to come by summer

State Dept. review finds Biden bears some blame for Afghanistan failures

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Sports medicine is finally prioritizing gender equality

Prosthetic arm enables patients to feel the objects they grip

leisure time

Childbirth

Brain worms: The science behind RFK Jr.'s parasitic infection

Dark money group runs ads on China biotech bill

How to improve immunocompromised access to mAb treatments

Medicare says breakthrough device reimbursement rule to come by summer

Shionogi licenses Pompe disease therapy from Maze Therapeutics

entertainment

explore

entertainment

focus